Envision Clinical Research Cen is categorized under Medical Labs in Fall River, MA and active since 2003.
Envision Clinical Research Cen was established in 2003, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Medical Labs business, which does work in the B2C market, and is classified as a Medical Labs, under code number 6215110 by the NAICS.
If you are seeking more information, feel free to contact Luisa Carreiro, President at the company’s single location by writing to 45 Ridge St, Fall River, Massachusetts MA 02721 or by phoning (508) 678-1816. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Envision Clinical Research Cen |
| Contact Person: | Luisa Carreiro, President |
| Address: | 45 Ridge St, Fall River, Massachusetts 02721 |
| Phone Number: | (508) 678-1816 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2003 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Medical Labs |
| SIC Code: | 8071 |
| NAICS Code: | 6215110 |
| Share This Business: |
Envision Clinical Research Cen was started in 2003 to provide professional Medical Labs under the SIC code 8071 and NAICS code 6215110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Luisa Carreiro, President for inquiries that concern Envision Clinical Research Cen by calling the company number (508) 678-1816, as your correspondence is most welcome. Additionally, the physical location of the single location of Envision Clinical Research Cen can be found at the coordinates 41.696686,-71.16013 as well as the street address 45 Ridge St in Fall River, Massachusetts 02721.
For its online presence, you may visit Envision Clinical Research Cen’s website at and engage with its social media outlets through on Twitter and on Facebook.